The data obtained in this study verified the effect of EFEMP1 in suppressing EGFR-driven cancer cell growth, and demonstrated a new activity of EFEMP1 in suppressing cell type/proportion change within a tumor, thereby maintaining existing intra-tumoral heterogeneity. Here, EGFR is linked to neoplasm.